Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Pfizer (NY: PFE)
42.91 USD  -0.61 (-1.40%)
Official Closing Price  /  Updated: 4:57 PM EST, Nov 14, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 26,591,792
Open 43.76
Bid (Size) 42.78 (1)
Ask (Size) 43.12 (1)
Prev. Close 43.52
Today's Range 42.71 - 43.85
52wk Range 33.20 - 45.81
Shares Outstanding 5,849,571,048
Dividend Yield 3.12%
Performance
YTD
+17.76%
+17.76%
1 Month
-0.49%
-0.49%
3 Month
+5.40%
+5.40%
6 Month
+20.23%
+20.23%
1 Year
+21.56%
+21.56%
Top News
More News
UPDATE 2-Pfizer loses drug patent fight in UK top court, may face claims
* Drugmaker says court decision a setback for innovation (Adds NHS, lawyer comment on possible claims against Pfizer) Read More
category companyNews
from Reuters: Company News
IVE, WMT, PFE, MRK: Large Inflows Detected at ETF
Symbols mentioned in this story: IVE, WMT, PFE, MRK Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
More News
Read More
Cutting-edge biotech Sangamo stock dives 13% after JPMorgan cites ‘growing skepticism’ in downgrade
category Biotechnology , Pharmaceuticals , SPX , and 11 more.
from MarketWatch
UPDATE 1-Pfizer loses blockbuster drug patent fight in UK Supreme Court
category companyNews
from Reuters: Company News
Pfizer loses Lyrica drug patent fight in UK Supreme Court
category companyNews
from Reuters: Company News
Walmart, Home Depot adopt health insurer tactic in drug copay battle
category companyNews
from Reuters: Company News
October's biggest Losers And Most Surprising Winners
category KO , Benzinga , Markets , and 11 more.
from Benzinga
Pfizer Becomes #10 Most Shorted Dow Stock, Replacing Exxon Mobil
category Stocks
from Market News Video
These Biopharmas Could Cure Genetic Diseases — At $5 Million Apiece
from Investor's Business Daily
Investors are flocking to 'quality' stocks. Here's what that means for the market
category McDonald's Corp , Amgen Inc , Invesco S&P 500 High ETF , and 6 more.
from CNBC.com News
These Biopharmas Could Cure Genetic Diseases — At $5 Million Apiece
from Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.